Patents by Inventor Ruth Oliver

Ruth Oliver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11884737
    Abstract: The present invention relates to a method of treating an autoimmune or inflammatory disease or a neurodegenerative disease with an antibody to CD154.
    Type: Grant
    Filed: June 29, 2021
    Date of Patent: January 30, 2024
    Assignees: UCB BIOPHARMA SRL, BIOGEN MA INC.
    Inventors: Ruth Oliver, Miren Zamacona
  • Publication number: 20230287100
    Abstract: The invention relates to therapeutic uses of antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F in the treatment of dermatological and rheumatological diseases, such as psoriasis, psoriatic arthritis and axial spondyloarthritis.
    Type: Application
    Filed: October 11, 2022
    Publication date: September 14, 2023
    Inventors: Sophie Glatt, Lucian Ionescu, Margaret Jones, Ruth Oliver, Stevan Graham Shaw, Foteini Strimenopoulou, Venkata Pavan Kumar Vajjah
  • Publication number: 20230279093
    Abstract: The invention relates to therapeutic uses of antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F in the treatment of dermatological and rheumatological diseases, such as psoriasis, psoriatic arthritis and axial spondyloarthritis.
    Type: Application
    Filed: October 11, 2022
    Publication date: September 7, 2023
    Inventors: Sophie Glatt, Lucian Ionescu, Margaret Jones, Ruth Oliver, Stevan Graham Shaw, Foteini Strimenopoulou, Venkata Pavan Kumar Vajjah
  • Patent number: 11492396
    Abstract: The invention relates to therapeutic uses of antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F in the treatment of dermatological and rheumatological diseases, such as psoriasis, psoriatic arthritis and axial spondyloarthritis.
    Type: Grant
    Filed: October 26, 2016
    Date of Patent: November 8, 2022
    Assignee: UCB BIOPHARMA SRL
    Inventors: Sophie Glatt, Lucian Ionescu, Margaret Jones, Ruth Oliver, Stevan Graham Shaw, Foteini Strimenopoulou, Venkata Pavan Kumar Vajjah
  • Publication number: 20210324095
    Abstract: The present invention relates to a method of treating an autoimmune or inflammatory disease or a neurodegenerative disease with an antibody to CD154.
    Type: Application
    Filed: June 29, 2021
    Publication date: October 21, 2021
    Inventors: RUTH OLIVER, MIREN ZAMACONA
  • Publication number: 20190292255
    Abstract: The invention relates to therapeutic uses of antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F in the treatment of dermatological and rheumatological diseases, such as psoriasis, psoriatic arthritis and axial spondyloarthritis.
    Type: Application
    Filed: October 26, 2016
    Publication date: September 26, 2019
    Inventors: Sophie Glatt, Lucian Ionescu, Margaret Jones, Ruth Oliver, Stevan Graham Shaw, Foteini Strimenopoulou, Venkata Pavan Kumar Vajjah
  • Publication number: 20180022812
    Abstract: The present invention relates to a method of treating an autoimmune or inflammatory disease or a neurodegenerative disease with an antibody to CD154.
    Type: Application
    Filed: April 27, 2015
    Publication date: January 25, 2018
    Inventors: RUTH OLIVER, MIREN ZAMACONA
  • Patent number: 6770262
    Abstract: The present invention is directed to a method for the treatment of gastroparesis by the use of metoclopramide nasal formulation.
    Type: Grant
    Filed: March 29, 2001
    Date of Patent: August 3, 2004
    Assignee: Questcor Pharmaceuticals, Inc.
    Inventors: Laura S. Lehman, David Tierney, Anastassios D. Retzios, Michael Petrone, David Young, Carol B. Trapnell, Ruth Oliver
  • Publication number: 20030059374
    Abstract: The present invention is directed to a method for the treatment of gastroparesis by the use of metoclopramide nasal formulation.
    Type: Application
    Filed: August 15, 2002
    Publication date: March 27, 2003
    Inventors: Laura S. Lehman, David Tierney, Anastassios D. Retzios, Michael Petrone, David Young, Carol B. Trapnell, Ruth Oliver
  • Publication number: 20020065321
    Abstract: The present invention is directed to a method for the treatment of gastroparesis by the use of metoclopramide nasal formulation.
    Type: Application
    Filed: March 29, 2001
    Publication date: May 30, 2002
    Inventors: Laura S. Lehman, David Tierney, Anastassios D. Retzios, Michael Petrone, David Young, Carol B. Trapnell, Ruth Oliver
  • Patent number: 4808162
    Abstract: A gastrotomy tube stabilizer comprises an upper, dome-shaped shell and a lower, cup-shaped shell. The lower shell remains affixed to the patient's skin and has a central aperture sufficiently large to permit passage of the gastrotomy tube therethrough and to leave the surrounding wound area exposed. The upper shell has a collar extending upwardly therefrom adapted to retain the gastrotomy tube, and is furnished with plural holes for ventilation. The upper and lower shells are furnished with cooperating interlocking means. When the shells are joined, a protective cavity is formed surrounding the wound area and the position of the gastrotomy tube is maintained. The upper shell may be readily disengaged from the lower shell to afford visual inspection of the wound area and access thereto for cleaning and changing of dressings.
    Type: Grant
    Filed: January 19, 1988
    Date of Patent: February 28, 1989
    Inventor: Ruth Oliver